Showing results (1121-1130 of 1,240) with videos related to
Sort By:
Pageof 124
Bone Marrow Transplantation|September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendationsR Greco, A Ruggeri, D P McLornan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00Renato Bassan, Giuseppe Rossi, Enrico M Pogliani, et al.Experimental Hematology|July 25, 2016
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromesFabrice Danjou, Claudio Fozza, Magdalena Zoledziewska, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.Journal of Hematology & Oncology|May 29, 2021
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.Occupational and Environmental Medicine|January 14, 2022
Night shift work and lymphoma: results from an Italian multicentre case-control studyPierluigi Cocco, Sara Piro, Federico Meloni, et al.ACS Chemical Biology|May 26, 2018
Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH EntryIlaria Silvestri, Haining Lyu, Francesca Fata, et al.Haematologica|July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter studyUmberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.Therapeutic Advances in Medical Oncology|August 28, 2019
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world settingAnna Di Benedetto, Cristiana Ercolani, Laura Pizzuti, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Symbolic use of marine shells and mineral pigments by Iberian NeandertalsJoão Zilhão, Diego E Angelucci, Ernestina Badal-García, et al.Pageof 124